Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
City & Markets

MiNK Therapeutics Reports Third Quarter 2026 Results and First Pre-Commercial Product Revenue

Trade Hub UK briefing (2026-11-13): MiNK Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, recognizing its first pre-commercial product revenue of… Primary source: original at Nasdaq (nasdaq.com).

By Nasdaq

MiNK Therapeutics Reports Third Quarter 2026 Results and First Pre-Commercial Product Revenue

MiNK Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, recognizing its first pre-commercial product revenue of $0.2 million from its lead candidate, agenT-797. This revenue was generated through its international named-patient acces

Read at source

Read also
  1. Digi International Reports Fourth Fiscal Quarter and Full Year Fiscal 2026 Results
  2. Nebius Group N.V. Reports Q3 2026 Financial Results and Updates Guidance
  3. Banco Santander-Chile Reports Net Income of 1,005,679 MCh$ for Period Ended October 31, 2026
  4. Asia Pacific Wire & Cable Corporation Limited Reports Quarterly Revenue of $161.7 million
  5. ZeroStack Corp. Dismisses Davidson & Company, LLP on November 5, 2026

Source: Nasdaq